U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H30N2O2.ClH
Molecular Weight 390.947
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BARUCAINIDE HYDROCHLORIDE

SMILES

Cl.CC(C)NCCCCOC1=C2COCC2=C(CC3=CC=CC=C3)N=C1C

InChI

InChIKey=NDUAUQZNHSFJMY-UHFFFAOYSA-N
InChI=1S/C22H30N2O2.ClH/c1-16(2)23-11-7-8-12-26-22-17(3)24-21(19-14-25-15-20(19)22)13-18-9-5-4-6-10-18;/h4-6,9-10,16,23H,7-8,11-15H2,1-3H3;1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C22H30N2O2
Molecular Weight 354.4858
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Barucainide, an IB anti-arrhythmic agent, was evaluated in patients with coronary artery disease. Its antiarrhythmic effect was studied in patients with markedly depressed left-ventricular function. Barucainide was in phase II clinical trials to treat the patients with arrhythmias but the development of the drug was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Investigation of the pharmacokinetic behavior of barucainide in man during an early phase I study.
1992 Nov
Patents

Sample Use Guides

The pharmacokinetic behavior of the class Ib antiarrhythmic drug barucainide was investigated in a phase I study in a group of 6 healthy male volunteers after oral administration of an initial single dose of 20 mg and incremental doses between 30 and 70 mg barucainide hydrochloride.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:12:34 GMT 2023
Edited
by admin
on Fri Dec 15 15:12:34 GMT 2023
Record UNII
RFI1WXG626
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BARUCAINIDE HYDROCHLORIDE
Common Name English
4-((1,3-DIHYDRO-6-METHYL-4-(PHENYLMETHYL)FURO(3,4-C)PYRIDIN-7-YL)OXY)-N-(1-METHYLETHYL)-1-BUTANAMINE HYDROCHLORIDE
Systematic Name English
1-BUTANAMINE, 4-((1,3-DIHYDRO-6-METHYL-4-(PHENYLMETHYL)FURO(3,4-C)PYRIDIN-7-YL)OXY)-N-(1-METHYLETHYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
301-208-7
Created by admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
PRIMARY
CAS
93982-17-3
Created by admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
PRIMARY
FDA UNII
RFI1WXG626
Created by admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
PRIMARY
EPA CompTox
DTXSID40240120
Created by admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
PRIMARY
PUBCHEM
146794
Created by admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY